Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tilray Brands Inc (TLRY)

Tilray Brands Inc (TLRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 751,470
  • Shares Outstanding, K 116,507
  • Annual Sales, $ 821,310 K
  • Annual Income, $ -2,187 M
  • EBIT $ -2,172 M
  • EBITDA $ -2,028 M
  • 60-Month Beta 1.95
  • Price/Sales 0.88
  • Price/Cash Flow 4.30
  • Price/Book 0.05

Options Overview Details

View History
  • Implied Volatility 101.56% (+5.98%)
  • Historical Volatility 42.09%
  • IV Percentile 25%
  • IV Rank 17.90%
  • IV High 221.71% on 06/09/25
  • IV Low 75.35% on 05/07/25
  • Expected Move (DTE 2) 0.31 (4.72%)
  • Put/Call Vol Ratio 0.08
  • Today's Volume 8,832
  • Volume Avg (30-Day) 8,053
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 492,656
  • Open Int (30-Day) 657,994
  • Expected Range 6.35 to 6.97

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 02/28/26
See More
  • Average Estimate -0.14
  • Number of Estimates 3
  • High Estimate -0.08
  • Low Estimate -0.18
  • Prior Year -1.00
  • Growth Rate Est. (year over year) +86.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.12 +8.82%
on 03/23/26
8.09 -17.68%
on 02/25/26
-1.26 (-15.91%)
since 02/24/26
3-Month
6.12 +8.82%
on 03/23/26
10.13 -34.24%
on 01/15/26
-3.49 (-34.38%)
since 12/24/25
52-Week
3.51 +89.91%
on 06/23/25
23.20 -71.29%
on 10/09/25
-0.16 (-2.39%)
since 03/24/25

Most Recent Stories

More News
Tilray Medical Announces Major Expansion of Medical Cannabis Portfolio in Australia

NEW YORK and SYDNEY, March 19, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, a recognized global leader in medical cannabis and a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY), today...

TLRY.TO : 9.19 (+4.31%)
TLRY : 6.66 (+3.26%)
Breckenridge Distillery Expands Its Colorado Presence with Cheba Hut Partnership

BRECKENRIDGE, Colo., March 18, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery , an award-winning craft distillery and spirits brand by  Tilray Brands, Inc .  (NASDAQ: TLRY; TSX: TLRY is excited...

TLRY.TO : 9.19 (+4.31%)
TLRY : 6.66 (+3.26%)
Tilray Brands Enters Agreement to Acquire BrewDog’s Key U.S. Assets, Expanding Its U.S. Craft Beer Platform

NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”, “our”, “we” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods...

TLRY.TO : 9.19 (+4.31%)
TLRY : 6.66 (+3.26%)
Tilray Medical, CC Pharma, and 14U Pharma Announce Strategic Alliance with “gesund leben” Cooperation and Alliance Healthcare Deutschland to Accelerate Market Expansion and Strengthen Pharmacy Access Across Germany

DENSBORN, Germany, March 12, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma, the pharmaceutical division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), has announced a strategic partnership with Tilray Medical,...

TLRY.TO : 9.19 (+4.31%)
TLRY : 6.66 (+3.26%)
Lighter. Cheaper. Funner. Pub Light Is Here.

BEND, Ore., March 11, 2026 (GLOBE NEWSWIRE) -- Pub Beer , the Cheap Fun beer brand by Tilray Brands, Inc . (Nasdaq: TLRY; TSX: TLRY), today announced the launch of Pub Light , a new American-style...

TLRY.TO : 9.19 (+4.31%)
TLRY : 6.66 (+3.26%)
Tilray Brands Acquires BrewDog Australia, Establishing Strategic Base to Accelerate Global Beverage and Consumer Products Growth Across the Asia-Pacific Region

Acquisition Includes BrewDog’s Profitable Australian Operations Including Brisbane Brewery and Two Flagship Bars Transaction Positions Tilray to Scale BrewDog Across Australia’s National Retail...

TLRY.TO : 9.19 (+4.31%)
TLRY : 6.66 (+3.26%)
Tilray Brands Acquires BrewDog, a Leading Global Craft Brand, Creating a ~$500 Million Global Craft Beer and Beverage Platform

Accretive Acquisition of Select Assets Includes Global Brand, UK Brewing Operations and 11 Strategic Brewpubs  Expected to Generate ~$200 Million in Annual Net Revenue and ~$6 - $8 Million of Adjusted...

TLRY.TO : 9.19 (+4.31%)
TLRY : 6.66 (+3.26%)
Good Supply Cannabis Brand Expands High-Potency Portfolio with New Spring Lineup Across Canada

TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage and wellness...

TLRY.TO : 9.19 (+4.31%)
TLRY : 6.66 (+3.26%)
Tilray Brands and the Carlsberg Group Enter into an Exclusive Multi-Year U.S. Brewing and Commercial Partnership

NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), a leading global consumer packaged goods company and the fourth-largest craft beer brewer in the United States,...

TLRY.TO : 9.19 (+4.31%)
TLRY : 6.66 (+3.26%)
Tilray Expands UK Pharmaceutical Access Through Strategic Agreement with Smartway Pharmaceuticals

NEW YORK and LONDON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Tilray Pharma the pharmaceutical division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), today announced that its European pharmaceutical distribution...

TLRY.TO : 9.19 (+4.31%)
TLRY : 6.66 (+3.26%)

Business Summary

Tilray Brands Inc. is a cannabis-lifestyle and consumer packaged goods company. It operates principally in Canada, the United States, Europe, Australia and Latin America. Tilray Brands Inc., formerly known as Tilray Inc., is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 7.23
2nd Resistance Point 6.97
1st Resistance Point 6.82
Last Price 6.66
1st Support Level 6.41
2nd Support Level 6.15
3rd Support Level 6.00

See More

52-Week High 23.20
Fibonacci 61.8% 15.68
Fibonacci 50% 13.35
Fibonacci 38.2% 11.03
Last Price 6.66
52-Week Low 3.51

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.